Theralase Technologies Inc. V.TLT

Poster for New Osmium PS with Hypoxic Phototoxicity

[Eoganacht]

Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy

[fredgoodwinson]

Thanks again Eog - the title says it all really: ‘Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy’.   If only the poster could add - ‘coming soon to a melanoma near you’.

[Eoganacht]

You said it Fred. Also - "The latest addition to Theralase's Intellectual Property Portfolio, which will eventually make it an irresistible buyout target"

[fredgoodwinson]

Tend to go along with that - the breadth of TLT`s knowledge and grip over the IP on all this amazing tech will surely prove irresistible to the first Big Pharma boss bright enough to appreciate the significance - but wouldn`t hold your breath on that one!

[Eoganacht]

I'm thinking 2022

[fredgoodwinson]

That would be fine!

[gojotv!]

So glad the news is getting out! When I had the pleasure of attending Dr. McFarland's last lecture at U.B.C., she talked about Rutherin-based PDC's, but forcussed more thoroughly on the (then) upcoming Osmium-based ones. She was proud to share preliminary findings that pointed to it being the PDC of choice for several anti-cancer applications, Rutherrin and Os-04 provide a one-two punch